MAPT and Alzheimer disease: This mouse model allows evaluation of the functional interactions that occur with concurrent Aβ and tau pathology, as well as the contribution to other pathological features of AD, such as neuroinflammation, cerebrovascular dysfunction, and cognitive deficits (Tai et al., 2021).